|
|
Tenofovir-Based HIV Postexposure Prophylaxis Promising
|
| Link ID |
5033 |
| Title |
Tenofovir-Based HIV Postexposure Prophylaxis Promising |
| Url |
http://www.medscape.com/viewarticle/573186?src=rss |
| Description |
Use of once-daily tenofovir DF along with lamivudine or emtricitabine may be more effective than previous regimens for non-occupational postexposure prophylaxis (NPEP) in people at high risk for HIV infection, investigators report in the April 1st issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Apr 19, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
Syringe Exchange Programs -- United States, 2005
|
|
|
Monitoring syringe exchange activity is key to assessing HIV prevention measures in the US. What were the syringe exchange program activities in the US in 2005? Any changes compared to previous years?
Morbidity & Mortality Weekly Report
|
| 3. |
Abbott to Settle Lawsuit Over HIV Drug Pricing
|
|
|
Abbott Laboratories has agreed to pay between $10 million and $27.5 million to settle a lawsuit contending it improperly raised the price of its HIV drug Norvir by 400 percent. Reuters Health Information
|
|
|